» Articles » PMID: 29079470

Small Molecule Alteration of RNA Sequence in Cells and Animals

Overview
Specialty Biochemistry
Date 2017 Oct 29
PMID 29079470
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

RNA regulation and maintenance are critical for proper cell function. Small molecules that specifically alter RNA sequence would be exceptionally useful as probes of RNA structure and function or as potential therapeutics. Here, we demonstrate a photochemical approach for altering the trinucleotide expanded repeat causative of myotonic muscular dystrophy type 1 (DM1), r(CUG). The small molecule, 2H-4-Ru, binds to r(CUG) and converts guanosine residues to 8-oxo-7,8-dihydroguanosine upon photochemical irradiation. We demonstrate targeted modification upon irradiation in cell culture and in Drosophila larvae provided a diet containing 2H-4-Ru. Our results highlight a general chemical biology approach for altering RNA sequence in vivo by using small molecules and photochemistry. Furthermore, these studies show that addition of 8-oxo-G lesions into RNA 3' untranslated regions does not affect its steady state levels.

Citing Articles

Heterobifunctional small molecules to modulate RNA function.

Kovachka S, Tong Y, Childs-Disney J, Disney M Trends Pharmacol Sci. 2024; 45(5):449-463.

PMID: 38641489 PMC: 11774243. DOI: 10.1016/j.tips.2024.03.006.


Targeting RNA with Small Molecules To Capture Opportunities at the Intersection of Chemistry, Biology, and Medicine.

Disney M J Am Chem Soc. 2019; 141(17):6776-6790.

PMID: 30896935 PMC: 6541398. DOI: 10.1021/jacs.8b13419.


Molecular Therapies for Muscular Dystrophies.

Lin A, Wang L Curr Treat Options Neurol. 2018; 20(7):27.

PMID: 29926204 DOI: 10.1007/s11940-018-0509-2.


Targeting RNA in mammalian systems with small molecules.

Donlic A, Hargrove A Wiley Interdiscip Rev RNA. 2018; 9(4):e1477.

PMID: 29726113 PMC: 6002909. DOI: 10.1002/wrna.1477.

References
1.
Thomas J, Hergenrother P . Targeting RNA with small molecules. Chem Rev. 2008; 108(4):1171-224. DOI: 10.1021/cr0681546. View

2.
Yu Z, Teng X, Bonini N . Triplet repeat-derived siRNAs enhance RNA-mediated toxicity in a Drosophila model for myotonic dystrophy. PLoS Genet. 2011; 7(3):e1001340. PMC: 3060073. DOI: 10.1371/journal.pgen.1001340. View

3.
Pushechnikov A, Lee M, Childs-Disney J, Sobczak K, French J, Thornton C . Rational design of ligands targeting triplet repeating transcripts that cause RNA dominant disease: application to myotonic muscular dystrophy type 1 and spinocerebellar ataxia type 3. J Am Chem Soc. 2009; 131(28):9767-79. PMC: 2731475. DOI: 10.1021/ja9020149. View

4.
Yeung M, Bennasser Y, Jeang K . miRNAs in the biology of cancers and viral infections. Curr Med Chem. 2007; 14(2):191-7. DOI: 10.2174/092986707779313417. View

5.
Rzuczek S, Colgan L, Nakai Y, Cameron M, Furling D, Yasuda R . Precise small-molecule recognition of a toxic CUG RNA repeat expansion. Nat Chem Biol. 2016; 13(2):188-193. PMC: 5290590. DOI: 10.1038/nchembio.2251. View